Longevity: mechanisms versus human outcomes

A product page lists "autophagy support", "senescence defence" and "NAD+ boost" in the same bullet list, and suddenly it sounds as though ageing has a tidy to-do list. It doesn't, and the gap between what a mechanism diagram shows and what a person can expect from a capsule is the whole story of longevity supplements. Here's how to read that gap.

A longevity label tells you how it is sold

A "longevity supplement" is a marketing category, not a regulatory or scientific one. The label tells you how something is sold, not what it has been shown to do or whether it suits you. Most of the ideas behind these products come from laboratory and animal research into how cells age. Human trials, where they exist, mostly measure blood markers, and the step from a changed marker to living longer or staying healthier longer has generally not been tested. In the Netherlands and the EU, the legal status of individual ingredients also varies, and it can change.

What the hallmarks of ageing are (and aren't)

The framework behind most longevity marketing comes from a 2023 review in Cell, "Hallmarks of aging: An expanding universe" (López-Otín et al., PubMed). It proposes twelve interconnected hallmarks: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis. The authors describe them as interconnected, and as features that appear with age, speed up ageing when experimentally pushed and offer possible points for intervention.

That is a map for researchers. It isn't a shopping list. Because the hallmarks overlap, a product said to "cover" ten of them hasn't delivered ten separate benefits, and it hasn't shown that the combination is safe.

Three terms you'll keep meeting

Autophagy is the cell's recycling process, and "disabled macroautophagy" is one of the twelve hallmarks. It's a genuine area of research. What a supplement does to it in a living person is a separate question, and "supports autophagy" on a label is a claim about a mechanism, not a measured result in people.

Cellular senescence is another hallmark, and it too is named in the same review. The same logic applies: a compound can affect senescence markers in a lab dish, and that is a different thing from an outcome you would notice.

NAD is a molecule involved in cell metabolism, and NAD "boosters" such as NMN and nicotinamide riboside are among the best-known longevity products. A 2026 systematic review of 113 studies (33 in humans, 80 in rodents) found that in people, oral nicotinamide riboside and NMN consistently raised their intended biochemical targets and were well tolerated over weeks to months. Effects on functional, metabolic, vascular and other healthspan-related outcomes were mixed, often null or specific to a single endpoint, and the authors concluded that clinical effectiveness for anti-ageing or wellness remains inconclusive (Gallagher & Emmanuel, 2026, Ageing Research Reviews, systematic review).

Mechanism, marker or outcome?

Longevity claims tend to sit on different rungs of evidence, from lab mechanism to outcome that matters to a person, and each rung needs its own evidence.

• The claim: "Targets a hallmark of ageing"; The rung: Mechanism in a lab or animal experiment; The question to ask: In which model, and what exactly changed?
• The claim: "Raises NAD levels"; The rung: Marker in people; The question to ask: Was it measured in humans, in a preparation like the one being sold?
• The claim: "Improves biological age"; The rung: Marker with an interpretation attached; The question to ask: Has that measurement been validated against real health outcomes?
• The claim: "Supports healthy ageing" or "extends healthspan"; The rung: Outcome that matters to a person; The question to ask: Was it measured in a human trial of sensible length?
• The claim: "Covers ten hallmarks"; The rung: A count of mechanisms; The question to ask: Was this exact combination tested for benefit and for safety?

An animal lifespan result is interesting research context. It isn't a human lifespan result. And a number from a biological-age app is not a clinical assessment; before paying for repeated tests, it's fair to ask what result would change a decision and whether anyone has validated that interpretation.

Before you add anything: the safety basics

A plausible ageing mechanism doesn't tell you a product is suitable for you. The US National Center for Complementary and Integrative Health (NCCIH) makes several points that apply to every longevity product (NCCIH, Using dietary supplements wisely):

• Supplements bought in shops or online "may differ in important ways from products tested in studies", so a study's preparation and your product are not automatically the same thing.
• They may interact with medicines or carry risks if you have certain medical problems or are going to have surgery. Some can increase the risk of bleeding or affect the response to anaesthesia.
• If side effects occur, stop the supplement and contact a healthcare provider.
• The amount of scientific evidence "varies widely": a lot on some supplements, very little on others.

Putting that to use is mostly a matter of record-keeping. Write down every product you take with its full label and why you take it, and take that list to a pharmacist or doctor before adding anything new. A trial dose describes an experiment, not a safe ceiling for everyone, and nobody here can tell you an amount. Our note on supplements and medicines explains the interaction side in more detail, and our guide to reading supplement labels covers what a label can and can't tell you.

Where EU rules come in

EU supplement law harmonises rules for vitamins and minerals under Directive 2002/46/EC, while other substances are less tightly specified at EU level, and member states may also require notification of products placed on their market (European Commission, food supplements). None of that is evidence that a product slows ageing.

Newer ingredients can also be a novel-food question. As one example, in May 2026 the European Food Safety Authority published a positive safety opinion on a synthetic form of NMN for adults at up to 300 mg a day, excluding pregnant and breastfeeding women (EFSA Journal 2026). An EFSA opinion is a scientific assessment, not a marketing authorisation, and trade press reported on 13 May 2026 that the Commission and Member States would now review it, with formal authorisation still to come (NutraIngredients, 13 May 2026). We couldn't confirm the EU novel-food status of NMN since then, so we make no statement about it. Check the Commission's Novel Food Status Catalogue before buying, and the rules of the country you shop in.

One ingredient, one evidence base

This page is deliberately an orientation. Each ingredient has different evidence, so we don't blend them into one longevity verdict. A stack scored by the number of hallmarks it touches is counting mechanisms, not benefits.

Turning curiosity into a useful question

Start with what you actually want: help with a diagnosed problem, a nutritional gap, physical function or a broad promise about ageing. They are different questions. For a specific product, write down the intended benefit, the exact ingredients, the human evidence and what remains unknown, then bring that to a pharmacist or doctor. Being interested in the science is fine, and curiosity doesn't need a basket.

Written by Smart Supplements with AI assistance from the sources linked in the text. It has not been reviewed by a clinician.

Last updated: 12 October 2026

This article is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before starting any new supplement, especially if you take prescription medication.